(Hong Kong, 20 February 2006) - Lee's Pharmaceutical Holdings Limited (GEM Stock: 8221: Website: www.leespharm.com) announced today that the application for clinical study for the Group's in-house product~Declotana® (Antiplatelet Thrombolysin injection) has been approved by the SFDA of China.